相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibody-drug conjugates-an emerging class of cancer treatment
Nikolaos Diamantis et al.
BRITISH JOURNAL OF CANCER (2016)
Immunogenicity of long-lasting recombinant factor VIII products
Mathieu Ing et al.
CELLULAR IMMUNOLOGY (2016)
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Andrea Wang-Gillam et al.
LANCET (2016)
Long-term monitoring for nanomedicine implants and drugs
Michaela Kendall et al.
NATURE NANOTECHNOLOGY (2016)
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
Susan Ashton et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy
Marina A. Dobrovolskaia
JOURNAL OF CONTROLLED RELEASE (2015)
Design considerations for nanotherapeutics in oncology
Triantafyllos Stylianopoulos et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial
Alexander N. Kharlamov et al.
NANOSCALE (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging
Yi-Xiang J. Wang
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Emerging Applications for Ferumoxytol as a Contrast Agent in MRI
Mustafa R. Bashir et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Emerging methods for the fabrication of polymer capsules
Jiwei Cui et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2014)
Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes Into Drugs, 2nd Edition
D. M. Benbrook
CLINICAL INFECTIOUS DISEASES (2014)
Polymer therapeutics: Top 10 selling pharmaceuticals - What next?
Ruth Duncan
JOURNAL OF CONTROLLED RELEASE (2014)
Multimodal Polymer Nanoparticles with Combined 19F Magnetic Resonance and Optical Detection for Tunable, Targeted, Multimodal Imaging in Vivo
Barbara E. Rolfe et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Size-Dependent Effects of Gold Nanoparticles Uptake on Maturation and Antitumor Functions of Human Dendritic Cells In Vitro
Sergej Tomic et al.
PLOS ONE (2014)
Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?
Julie Marill et al.
RADIATION ONCOLOGY (2014)
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Evan Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
What nanomedicine in the clinic right now really forms nanoparticles?
Sonke Svenson
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2014)
Nanoparticle-Mediated Systemic Delivery of siRNA for Treatment of Cancers and Viral Infections
Mohamed Shehata Draz et al.
THERANOSTICS (2014)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Hyperthermia-induced drug targeting
Jonathan P. May et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
Ahmad Awada et al.
LANCET ONCOLOGY (2013)
A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study
Francine M. Foss et al.
LEUKEMIA & LYMPHOMA (2013)
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors
Neil Senzer et al.
MOLECULAR THERAPY (2013)
Therapeutic nanoparticles in clinics and under clinical evaluation
Catherine A. Schuetz et al.
NANOMEDICINE (2013)
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Michael L. Etheridge et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Size dependence of Au NP-enhanced surface plasmon resonance based on differential phase measurement
Shuwen Zeng et al.
SENSORS AND ACTUATORS B-CHEMICAL (2013)
Nanotheranostics for personalized medicine
Simona Mura et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Fangqiong Tang et al.
ADVANCED MATERIALS (2012)
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Alexandre Albanese et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 14 (2012)
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
Rajib Ghosh Chaudhuri et al.
CHEMICAL REVIEWS (2012)
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Nazila Kamaly et al.
CHEMICAL SOCIETY REVIEWS (2012)
Design of polymeric nanoparticles for biomedical delivery applications
Mahmoud Elsabahy et al.
CHEMICAL SOCIETY REVIEWS (2012)
The golden age: gold nanoparticles for biomedicine
Erik C. Dreaden et al.
CHEMICAL SOCIETY REVIEWS (2012)
A Novel PEGylated Interferon Beta-1a for Multiple Sclerosis: Safety, Pharmacology, and Biology
Xiao Hu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Antibody-drug conjugates: Basic concepts, examples and future perspectives
Giulio Casi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Plasmonic Photothermic and Stem Cell Therapy of Atherosclerotic Plaque As a Novel Nanotool for Angioplasty and Artery Remodeling
Alexander N. Kharlamov et al.
REJUVENATION RESEARCH (2012)
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Jeffrey Hrkach et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis
Stefan Tenzer et al.
ACS NANO (2011)
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101
Sonke Svenson et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
Klaus Maier-Hauff et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Toxicological considerations of clinically applicable nanoparticles
Lara Yildirimer et al.
NANO TODAY (2011)
In vivo biodistribution of nanoparticles
Joao Paulo Mattos Almeida et al.
NANOMEDICINE (2011)
FDA-approved poly(ethylene glycol)-protein conjugate drugs
Steevens N. S. Alconcel et al.
POLYMER CHEMISTRY (2011)
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Steven K. Libutti et al.
CLINICAL CANCER RESEARCH (2010)
Rexin-G, a targeted genetic medicine for cancer
Erlinda M. Gordon et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives
Ranjita Shegokar et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Functional Hyperbranched Polymers: Toward Targeted in Vivo 19F Magnetic Resonance Imaging Using Designed Macromolecules
Kristofer J. Thurecht et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
Sant P. Chawla et al.
MOLECULAR THERAPY (2010)
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Chris Oerlemans et al.
PHARMACEUTICAL RESEARCH (2010)
Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture
Megan E. Fox et al.
ACCOUNTS OF CHEMICAL RESEARCH (2009)
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
Mark E. Davis
MOLECULAR PHARMACEUTICS (2009)
Understanding biophysicochemical interactions at the nano-bio interface
Andre E. Nel et al.
NATURE MATERIALS (2009)
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
L. Paz-Ares et al.
BRITISH JOURNAL OF CANCER (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Clinical applications of magnetic nanoparticles for hyperthermia
Burghard Thiesen et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2008)
Pharmacokinetics and biodistribution of nanoparticles
Shyh-Dar Li et al.
MOLECULAR PHARMACEUTICS (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
Nanoparticles in medicine: Therapeutic applications and developments
L. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Renal clearance of quantum dots
Hak Soo Choi et al.
NATURE BIOTECHNOLOGY (2007)
New method for the effective production of ultrafine drug nanocrystals
Jan Moeschwitzer et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2006)
Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
M. R. Green et al.
ANNALS OF ONCOLOGY (2006)
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel
N Desai et al.
CLINICAL CANCER RESEARCH (2006)
Clinical experience with denileukin diftitox (ONTAK)
F Foss
SEMINARS IN ONCOLOGY (2006)
Eligard®:: Pharmacokinetics, effect on testosterone and PSA levels and tolerability
R Berges
EUROPEAN UROLOGY SUPPLEMENTS (2005)
Novel fast degradable thermosensitive polymeric micelles based on PEG-block-poly(N-(2-hydroxyethyl)methacrylamide-oligolactates)
CJF Rijcken et al.
BIOMACROMOLECULES (2005)
Lipid-based amphotericin B: a review of the last 10 years of use
IM Hann et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
分享论文
